David M Leistner

researcher

David M Leistner is …
instance of (P31):
humanQ5

External links are
P227GND ID143548026
P496ORCID iD0000-0002-4351-420X
P214VIAF ID168188119

P734family nameLeistnerQ21487487
LeistnerQ21487487
LeistnerQ21487487
P735given nameDavidQ18057751
DavidQ18057751
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q33508959A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional reg
Q55021882Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain.
Q90831935Assessment of intermediate coronary lesions by fractional flow reserve and quantitative flow ratio in patients with small-vessel disease
Q90105569Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes
Q39540461Binary regression: total gain in positive and negative predictive values
Q64054921Bone marrow and plasma FGF-23 in heart failure patients: novel insights into the heart-bone axis
Q56610956Cardiovascular Events during World Cup Soccer
Q48788707Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention
Q51204762Comparison of the Seattle heart failure model and cardiopulmonary exercise capacity for prediction of death in patients with chronic ischemic heart failure and intracoronary progenitor cell application.
Q56970457Coronary Atherosclerotic Plaque Characteristics and Cardiovascular Risk Factors - Insights From an Optical Coherence Tomography Study
Q38452816Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial
Q38464940Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosis
Q41961843FD-OCT and IVUS for detection of incomplete stent apposition in heavily calcified vessels: novel insights
Q56140787From heart to toe: Heart's contribution on peripheral microRNA levels
Q56978508G-CSF Stimulation and Coronary Reinfusion of Mobilized Circulating Mononuclear Proangiogenic Cells in Patients with Chronic Ischemic Heart Disease: Five-Year Results of the TOPCARE-G-CSF Trial
Q34347691Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair
Q45236324Heparin selectively affects the quantification of microRNAs in human blood samples
Q50922597Immunosenescence-associated microRNAs in age and heart failure.
Q51801112Impact of concomitant mitral regurgitation on transvalvular gradient and flow in severe aortic stenosis: a systematic ex vivo analysis of a subentity of low-flow low-gradient aortic stenosis.
Q34683330Impact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure
Q40740507Impact of lipid metabolism parameters on the development and progression of coronary artery disease : An update
Q98957716Impact of real-time angiographic co-registered optical coherence tomography on percutaneous coronary intervention: the OPTICO-integration II trial
Q33866958Improved risk stratification in prevention by use of a panel of selected circulating microRNAs
Q33765384Intracoronary administration of bone marrow-derived mononuclear cells and arrhythmic events in patients with chronic heart failure
Q47198038Left atrial appendage angiography is associated with the incidence and number of magnetic resonance imaging-detected brain lesions after percutaneous catheter-based left atrial appendage closure
Q52843198Left atrial appendage closure in a patient with left atrial appendage thrombus using a novel fish ball technique.
Q35102931Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival
Q56957050Long-term follow up of 3 T MRI-detected brain lesions after percutaneous catheter-based left atrial appendage closure
Q48881035Modified serum profiles of inflammatory and vasoconstrictive factors in patients with emotional stress-induced acute coronary syndrome during World Cup Soccer 2006.
Q51041886Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.
Q48741878Novel Approach for In Vivo Detection of Vulnerable Coronary Plaques using Molecular 3-T CMR Imaging with an Albumin-Binding Probe
Q56978499Novel Avenues for Cell Therapy in Acute Myocardial Infarction
Q46409477One fits all or which stent for which lesion for which patient?
Q92863572Procedural and clinical performance of dual- versus single-catheter strategy for transradial coronary angiography: A meta-analysis of randomized trials
Q44594551Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study
Q48458812Prognostic value of reported chest pain for cardiovascular risk stratification in primary care
Q112277047Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism
Q47643084Real-time optical coherence tomography coregistration with angiography in percutaneous coronary intervention-impact on physician decision-making: The OPTICO-integration study
Q33546217Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy
Q56978491Regenerative Therapien bei fortgeschrittener Herzerkrankung
Q43476890Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information?
Q27312424Solid Right Ventricular Compression by Intraventricular Septum-Hematoma Induced after Percutaneous Coronary Intervention
Q39745795The DETECT adherence score--structure and psychometric exploration of a novel approach to measure adherence to drug and non-drug interventions in primary care.
Q42334160The relevance of periprocedural troponin rise: the never ending story!
Q40198987Transcoronary Concentration Gradient of microRNA-133a and Outcome in Patients With Coronary Artery Disease
Q56978474Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics
Q33919886Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy
Q50663676Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
Q52848552[Catheter-based closure of the left atrial appendage : Stroke prevention in atrial fibrillation].

Search more.